Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Tekmira Pharmaceuticals Corp TKMR

Sector: Healthcare | Sub-Sector: Biotechnology
Primary Symbol: T.TKM

Tekmira Pharmaceuticals Corp develops ribonucleic acid interference therapeutic product candidates as well as provides its lipid nanoparticle delivery technology to pharmaceutical partners in the Canada.
Price: $16.56 | Change: $-0.38 | %Change: -2.24%
Volume: 689,346 | Day High/Low: 17.50/16.50 | 52 Week High/Low: 31.48/7.17

Snapshot

Last Traded: October 31, 2014 08:52 Transaction Volume: 689,346
Open: $16.56 Previous Close: $16.94
Bid: $16.56 Ask: $16.67
Bid Size: 80 Ask Size: 100
Market Cap: $369.0m Shares Out: 22.3m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Opinion

The Calandra Report: BioCryst Pharma, nothing to sneeze at

Thom Calandra   October 15, 2014
0 stars

Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Latest Bullboard Posts